Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
How AI is Transforming Clinical Trials
AI is already reshaping the clinical trials industry and that transformation looks set to continue over the next five years. New technologies will enable the development of more personalized medicines, empower more responsive trial designs and improve informed decision making by unlocking new data insights. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Cytovance Adds Standalone Analytical Services
Wednesday, August 19, 2026
Cytovance Biologics has launched standalone analytical services for biopharmaceutical companies, allowing clients to access analytical testing without... read more
Piramal Pharma Takes Controlling Stake in Yapan Bio
Wednesday, August 19, 2026
Piramal Pharma Ltd. has completed the acquisition of an additional 40.67% stake in Hyderabad-based biologics contract development and manufacturing ... read more
Clinilabs Names Laura Shannon CEO; Founder Gary Zammit Becomes Executive Chair
Tuesday, August 18, 2026
Clinilabs has appointed biopharma executive Laura Shannon as chief executive officer and promoted founder Gary Zammit, Ph.D., to executive chairperson... read more
Genprex Selects U.S. CDMO to Scale Diabetes Gene Therapy Manufacturing
Tuesday, August 18, 2026
Genprex has selected a U.S.-based contract development and manufacturing organization to scale production of its investigational diabetes gene therapy... read more
Lonza Launches Rapid Custom Media Prototyping Service for Cell Culture
Tuesday, August 18, 2026
Lonza has launched a rapid custom media prototyping service designed to help life sciences customers accelerate early-stage development of cell ... read more